Cassava Science (SAVA) Stock Price Today & Analysis
SAVA
Valuation
Market cap$101.45M
Price-to-sales ratioN/A
Price-to-book valueN/A
Price-earnings ratio-1.00
Return on EquityN/A
Return on SalesN/A
Return on AssetsN/A
PEG ratioN/A
Earnings Per Share
Earnings Per Share$-2.22
Income Statement
Average volume1,003,648
EBITDAN/A
1 year high (52w)$4.98
1 year low (52w)$1.15
Dividend
Dividend yield0.00%
Solvency
Debt-to-equity ratioN/A
About Cassava Science
Cassava Sciences’ mission is to discover and develop innovations for chronic, neurodegenerative conditions. Over the past 10 years, Cassava Sciences has combined state-of-the-art technology with new insights in neurobiology to develop novel solutions for Alzheimer’s disease.
FAQ
You can easily purchase Cassava Science (SAVA) shares through the Gotrade app. Simply download the app, set up your account, fund it, and then search for the 'SAVA' ticker to begin your investment journey.
At Gotrade, you can kickstart your investment in Cassava Science with as little as $1.
Absolutely. Brokerage services on Gotrade Indonesia are provided by PT Valbury Asia Futures, a licensed futures and commodities broker registered with and supervised by the Indonesian Financial Services Authority (OJK).
Yes. Gotrade provides access to U.S. stocks from Indonesia through fully backed shares. This is facilitated through a cross-border order routing scheme for foreign stock derivative contracts (PALN), in accordance with regulations from Bappebti (the Commodity Futures Trading Regulatory Agency).
When you trade, you enter into a contract with PT Valbury Asia Futures (Valbury), a Bappebti-registered broker in Indonesia. Valbury, in turn, fully backs its contracts 1-for-1 with Alpaca Securities LLC, a FINRA-licensed broker-dealer in the United States. For every share (or fraction thereof) you hold on Gotrade, a corresponding share is held by Valbury in a separate, segregated brokerage account at Alpaca Securities LLC.
